Drugs / Charcotrace
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT03743259 Comparator | May 2018 → Jan 2019 | breast disorder | Hanlim Pharm. Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT04606329 Comparator | Jul 2020 → Jan 2021 | breast disorder | Hanlim Pharm. Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Charcotrace | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04606329 ↗ |
| Known as | Charcotrace Injection(Activated Charcoal 40mg/1ml) | “Charcotrace Injection(Activated Charcoal 40mg/1ml)” NCT03743259 ↗ |